Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

32.21
BATS BZX Real-Time Price
As of 3:51pm ET
 -0.63 / -1.92%
Today’s Change
20.39
Today|||52-Week Range
37.32
-3.85%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close32.84
Today’s open32.86
Day’s range32.20 - 32.86
Volume3,622
Average volume (3 months)231,138
Market cap$625.3M
Dividend yield--
Data as of 3:51pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratio28.5
Price/Sales5.80
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.03-0.34%
GBTGlobal Blood Therape...+0.05+0.30%
CLLSCellectis SA-0.11-0.62%
AKAOAchaogen Inc-1.23-6.53%
Data as of 3:53pm ET, 01/20/2017

Financials

Next reporting dateFebruary 6, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Jay R. Luly
CFO, Senior VP-Finance &
Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs